Are we there yet? Prolonged MAPK inhibition in BRAF(V600)-mutant melanoma.

MLA

Khushalani, Nikhil I., and Vernon K. Sondak. “Are We There yet? Prolonged MAPK Inhibition in BRAF(V600)-Mutant Melanoma.” Lancet Oncology, vol. 17, no. 9, Sept. 2016, pp. 1178–79. EBSCOhost, https://doi.org/10.1016/S1470-2045(16)30368-0.

APA

Khushalani, N. I., & Sondak, V. K. (2016). Are we there yet? Prolonged MAPK inhibition in BRAF(V600)-mutant melanoma. Lancet Oncology, 17(9), 1178–1179. https://doi.org/10.1016/S1470-2045(16)30368-0

Chicago

Khushalani, Nikhil I, and Vernon K Sondak. 2016. “Are We There yet? Prolonged MAPK Inhibition in BRAF(V600)-Mutant Melanoma.” Lancet Oncology 17 (9): 1178–79. doi:10.1016/S1470-2045(16)30368-0.